Alteration of peripheral blood lymphocyte subsets in acute pancreatitis

Figure 1 Peripheral blood lymphocytes in patients with AP. A: Total count; B: CD7+; C: CD19+; D: CD4+; E: CD8+; F: CD69+; G: CD25+. Results are expressed as mean ± SD. ^aP < 0.05 vs control; ^cP < 0.05 vs mild AP at the same day of observation.

Figure 2 Peripheral blood T-lymphocytes (CD7+) (A) and B-lymphocytes (CD19+) (B) expressing CD122 in patients with AP. Results are expressed as mean ± SD. ^aP < 0.05 vs control; ^cP < 0.05 vs mild AP at the same day of observation.

Figure 3 Peripheral blood CD8+ cells expressing CD38 (A) and CD28 (B) in patients with AP. Results are expressed as mean ± SD. ^aP < 0.05 vs control; ^cP < 0.05 vs mild AP at the same day of observation.

Figure 4 Markers of lymphocyte apoptosis in patients with AP. Peripheral blood lymphocytes expressing CD95 (A), CD3+ lymphocytes expressing Annexin V (B) and CD19+ lymphocytes expressing Annexin V (C). Results are expressed as mean ± SD. ^aP < 0.05 vs control; ^cP < 0.05 vs mild AP at the same day of observation.